|
Randy A. Kelley previously Vice President of Sales joined Onyx in September 2004. Mr. Kelley established Onyx's U.S. sales organization and managed with the company’s collaborator Bayer the successful launch of Nexavar a targeted oncology agent approved for the treatment of advanced kidney cancer. From 1994 to 2004 Mr. Kelley served in various senior sales and marketing positions at Chiron Corporation including Vice President North American sales for the company's biopharmaceutical division. Previously Mr. Kelley was Vice President of Sales at Immunex Corporation and held various sales management positions at Adria Laboratories. Mr. Kelley earned his B.A. from the University of the Pacific. He is a member of the Board of Directors of the William S. Graham Foundation for Melanoma Research. | 